Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
99 100 Next >
Lead Plaintiff Deadline is February 18, 2025 for Investors of Applied Therapeutics - Contact Kaplan Fox
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Lead Plaintiff Deadline is February 18, 2025 for Investors of Applied Therapeutics - Contact Kaplan Fox
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Semaglutide & Tirzepatide Injections For Weight Loss: 2025 Member Prices Updated
Via Press Release Distribution Service
Exposures Product Safety
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Positive Phase 1 Results for TNX-1500 in Transplant and Autoimmune Therapy
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
Molham Abdulsamad, MD, Joins the Actuated Medical – Medical Advisory Board
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Elon Musk Recalls A Lunch Where Charlie Munger Listed All The Reasons Tesla Would Fail — 'Made Me Quite Sad, But I Told Him I Agreed...'
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers BRK TSLA
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Enrolls First Patients in Phase 3 Alzheimer’s Trial
Via Investor Brand Network
Exposures Product Safety
Tickers ANVS
Arcutis Soared In 2024, Blazing Trails In Dermatology. Why Its CEO Eyes Bigger Gains.
Via Investor's Business Daily
Exposures Product Safety
Tickers ARQT AZN LLY PFE
Earnings Miss? Amgen’s Dividend Still a Bright Spot
Via MarketBeat
Exposures Product Safety
Tickers AMGN LLY NVO
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) CEO to Present at BIO CEO & Investor Conference
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
Biotech Investing: How PRV’s Can Unlock Major Opportunities (OSTX, DAWN, SWTX, PTCT)
Via AB Newswire
Exposures Product Safety
Tickers DAWN
Biotech Investing: How PRVs Can Unlock Major Opportunities
Via News Direct
Exposures Product Safety
Tickers DAWN
DiagnosTear Advances Production for First 100,000 TeaRx(TM) Red Eye Diagnostic Devices
Via TheNewswire.com
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers CSE:DTR
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Promotes Siobhan Fogarty to Chief Technical Officer
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
Vertex Pharma Just Scored a Major FDA Approval. Is the Stock a No-Brainer Buy Now?
Via The Motley Fool
Exposures Product Safety
Tickers VRTX
Applied Therapeutics, Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Applied Therapeutics, Inc. Investors Reminder: Kessler Topaz Meltzer &amp; Check, LLP Reminds Applied Therapeutics, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Kaplan Fox Alerts Applied Therapeutics, Inc. (APLT) Investors to a Securities Class Action Lawsuit - Deadline is February 18, 2025
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Kaplan Fox Alerts Applied Therapeutics, Inc. (APLT) Investors to a Securities Class Action Lawsuit - Deadline is February 18, 2025
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Announces 1-for-100 Reverse Stock Split
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy?
Via The Motley Fool
Exposures Product Safety
Tickers VRTX
Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?
Via The Motley Fool
Exposures Product Safety
Tickers CRSP VRTX
APLT DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on February 18, 2025
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
APLT DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on February 18, 2025
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
FDA Approves First Non-Opioid Pain Pill, As Medical Marijuana Remains A Proven Alternative For Relief
Via Benzinga
Topics Cannabis
Exposures Cannabis Product Safety
Tickers VRTX
Vertex Pharmaceuticals Stock Soars As Non-Opioid Pain Treatment Gets FDA Nod
Via Talk Markets
Topics Stocks / Equities
Exposures Product Safety
Tickers VRTX
APLT Deadline to Lead in Securities Fraud Lawsuit is February 18, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
APLT Deadline to Lead in Securities Fraud Lawsuit is February 18, 2025 - Contact Kaplan Fox &amp; Kilsheimer LLP
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
United Health Products Provides Update on FDA PMA Application Process
Via NewMediaWire
Exposures Product Safety
Tickers UEEC
United Health Products Provides Update on FDA PMA Application Process
Via TheNewswire.com
Exposures Product Safety
Tickers UEEC
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.